Pritchard KI - Search Results

1

Can improved communication increase patient participation in randomised clinical trials?

Sawka CA, Pritchard KI. Sawka CA, et al. Among authors: pritchard ki. Eur J Cancer. 2001 Feb;37(3):297-9. doi: 10.1016/s0959-8049(00)00434-2. Eur J Cancer. 2001. PMID: 11239751 No abstract available.

2

An improved statistical approach: can it clarify the role of new prognostic factors for breast cancer?

Chapman JW, Murray D, McCready DR, Hanna W, Kahn HJ, Lickley HL, Trudeau ME, Mobbs BG, Sawka CA, Fish EB, Pritchard KI. Chapman JW, et al. Among authors: pritchard ki. Eur J Cancer. 1996 Oct;32A(11):1949-56. doi: 10.1016/0959-8049(96)00232-8. Eur J Cancer. 1996. PMID: 8943680 Review.

3

Hormone replacement therapy after treatment for breast cancer: physicians' attitudes towards randomized trials.

Del Giudice ME, Sawka CA, Pritchard KI, Llewellyn-Thomas HA, Trudeau ME, Lewis JE, Franssen E. Del Giudice ME, et al. Among authors: pritchard ki. Breast Cancer Res Treat. 2003 May;79(2):213-23. doi: 10.1023/a:1023951616696. Breast Cancer Res Treat. 2003. PMID: 12825856

4

Menopausal estrogen replacement therapy in women with breast cancer.

Pritchard KI, Sawka CA. Pritchard KI, et al. Cancer. 1995 Jan 1;75(1):1-3. doi: 10.1002/1097-0142(19950101)75:1<1::aid-cncr2820750102>3.0.co;2-1. Cancer. 1995. PMID: 7804962 No abstract available.

5

A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis.

Bordeleau L, Rakovitch E, Naimark DM, Pritchard KI, Ackerman I, Sawka CA. Bordeleau L, et al. Among authors: pritchard ki. Cancer. 2001 Jul 1;92(1):23-9. doi: 10.1002/1097-0142(20010701)92:1<23::aid-cncr1287>3.0.co;2-y. Cancer. 2001. PMID: 11443605

6

Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?

Roy JA, Sawka CA, Pritchard KI. Roy JA, et al. Among authors: pritchard ki. J Clin Oncol. 1996 Mar;14(3):997-1006. doi: 10.1200/JCO.1996.14.3.997. J Clin Oncol. 1996. PMID: 8622051 Review.

7

The clinical practice guideline: an evolving health care technology.

Browman GP, Levine MN, Graham I, Whelan T, Sawka C, Pritchard KI, Jadad A, Newman TE. Browman GP, et al. Among authors: pritchard ki. Cancer Prev Control. 1997;1(1):7-8. Cancer Prev Control. 1997. PMID: 9765721 No abstract available.

8

Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.

Sawka CA, Pritchard KI, Paterson AH, Sutherland DJ, Thomson DB, Shelley WE, Myers RE, Mobbs BG, Malkin A, Meakin JW. Sawka CA, et al. Among authors: pritchard ki. Cancer Res. 1986 Jun;46(6):3152-6. Cancer Res. 1986. PMID: 3084082

9

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1.

Sawka CA, Pritchard KI, Shelley W, DeBoer G, Paterson AH, Meakin JW, Sutherland DJ. Sawka CA, et al. Among authors: pritchard ki. Breast Cancer Res Treat. 1997 Jul;44(3):211-5. doi: 10.1023/a:1005895813401. Breast Cancer Res Treat. 1997. PMID: 9266100 Clinical Trial.

10

Sex hormones and breast cancer: the issue of hormone replacement.

Pritchard KI, Roy JA, Sawka CA. Pritchard KI, et al. Recent Results Cancer Res. 1996;140:285-93. doi: 10.1007/978-3-642-79278-6_32. Recent Results Cancer Res. 1996. PMID: 8787071 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters